Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, see 15271-15274

Official Description

Tissue cultured allogeneic dermal substitute, trunk, arms, legs; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (List separately in addition to code for primary procedure)

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

A tissue cultured allogeneic dermal substitute is a specialized medical product used to treat wounds or skin defects on the trunk, arms, or legs. This substitute is derived from human fibroblast cells, which are essential components of the skin that help in the healing process. The fibroblasts are typically sourced from newborn foreskin tissue and are cultured in a laboratory setting. During this process, the fibroblasts are seeded onto a bioabsorbable mesh scaffold, which serves as a framework for the cells to grow and multiply. As the fibroblasts proliferate, they produce important substances such as human dermal collagen, matrix proteins, growth factors, and cytokines. These components play a crucial role in regulating the immune response and promoting healing. The end result is a metabolically active, living dermal substitute that can effectively cover and protect the wound site. When applying the dermal substitute, it is carefully removed from its transport container and placed onto a prepared wound bed. The substitute is then secured in place using sutures or staples to ensure it remains stable during the healing process. Following this, a layered dressing is applied to the area, which typically includes a nonadherent layer to prevent sticking, a bulky layer of gauze for absorption, a compression layer to support the area, and an anti-shear layer to minimize friction. For billing purposes, CPT® Code 15360 is used for the initial application of the first 100 square centimeters or less in adults, or for 1% of total body surface area (TBSA) in infants and children. CPT® Code 15361 is then utilized for each additional 100 square centimeters in adults or each additional 1% of TBSA in infants and children, or any part thereof.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The tissue cultured allogeneic dermal substitute is indicated for use in patients requiring coverage for wounds or skin defects located on the trunk, arms, or legs. This procedure is particularly relevant for individuals with extensive skin loss or damage, where traditional wound healing methods may be insufficient. The use of this dermal substitute is appropriate for both adults and pediatric patients, including infants and children, who may have varying percentages of total body surface area affected by wounds.

  • Wound Coverage The procedure is performed to provide coverage for wounds that may not heal adequately with standard treatments.
  • Skin Defects It is indicated for the treatment of skin defects resulting from trauma, surgical procedures, or other medical conditions.
  • Extensive Skin Loss The dermal substitute is particularly beneficial for patients with significant skin loss, where a more advanced treatment is necessary.

2. Procedure

The application of a tissue cultured allogeneic dermal substitute involves several critical steps to ensure proper placement and effectiveness. First, the wound bed must be adequately prepared, which may include cleaning the area and removing any necrotic tissue to promote optimal healing conditions.

  • Step 1: Preparation of the Wound Bed The healthcare provider cleans the wound area thoroughly, ensuring that it is free from debris and infection. This step is crucial for the successful integration of the dermal substitute.
  • Step 2: Application of the Dermal Substitute Once the wound bed is prepared, the tissue cultured allogeneic dermal substitute is carefully removed from its transport container. It is then placed directly onto the wound bed, ensuring complete coverage of the affected area.
  • Step 3: Securing the Substitute The dermal substitute is secured in place using sutures or staples, which help to maintain its position and protect it from movement or displacement during the healing process.
  • Step 4: Dressing Application After securing the dermal substitute, a layered dressing is applied. This dressing typically consists of a nonadherent layer to prevent sticking to the substitute, a bulky layer of gauze for absorption, a compression layer to support the area, and an anti-shear layer to minimize friction and protect the substitute from external forces.

3. Post-Procedure

Post-procedure care is essential to ensure the success of the tissue cultured allogeneic dermal substitute application. Patients are typically monitored for signs of infection or complications at the wound site. The layered dressing should remain intact and be changed according to the healthcare provider's instructions, which may vary based on the specific needs of the wound and the patient's overall condition. Patients may also receive guidance on how to care for the area, including instructions on keeping the site clean and dry. Follow-up appointments are important to assess the healing progress and determine if additional treatments or interventions are necessary.

Short Descr APLY CULT DERM SUB T/A/L ADD
Medium Descr TISSUE CLTR ALGC DERMAL T/A/L EA 100CM/EA 1 PCT
Long Descr TISSUE CLTR ALGC DERMAL T/A/L EA 100CM/EA 1 PCT
Status Code Active Code
Global Days ZZZ - Code Related to Another Service
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 1 - Statutory payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Discontinued Code
Type of Service (TOS) 2 - Surgery
Berenson-Eggers TOS (BETOS) none
MUE Not applicable/unspecified.
CCS Clinical Classification 172 - Skin graft
Date
Action
Notes
2012-01-01 Deleted Code deleted, see 15271-15274
2007-01-01 Changed Code description changed.
2006-01-01 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"